Remove Drug Development Remove Licensing Remove Molecular Biology Remove Pharmaceutical Companies
article thumbnail

Europe: Where is the drug discovery innovation?

Drug Discovery World

In this article, DDW’s Diana Spencer highlights several prominent hotspots that are taking the lead on advancing European drug discovery and development. Europe is traditionally a life sciences powerhouse, with a strong tradition in pharmaceutical discovery. In 2022, the continent held a 22.4%

Drugs 147
article thumbnail

Where is the promise for plant-based medicines? Part 1: Cannabis  

Drug Discovery World

There are also three synthetic cannabis-related drug products, which are Marinol (dronabinol), Syndros (dronabinol), and Cesamet (nabilone). Even still, these approved drug products require a licensed healthcare provider’s prescription. This damages the ability of scientists to bring facts rather than fiction to the industry.”

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Scaling Phage Therapy

Codon

Phage-based products have been licensed for use as antibacterial agents in the sanitation , food production , and animal health industries. The weakened dose of phages helped bacteria develop resistance, and the trial became yet another study that provided evidence phages are safe, but little more.

Therapies 118
article thumbnail

From the Top: Adele Hannigan, Antibody Analytics

Drug Discovery World

AH : I am Chief Business Officer for Antibody Analytics, a collaborative immunology CRO, specialising in supporting immunotherapy developers at the discovery to pre-clinical stages of the drug development process. I have now been with Antibody Analytics for three and half years. MT: Who or what inspires you?